Who Makes Adalimumab?

Adalimumab is a powerful prescription drug used to treat a variety of autoimmune and inflammatory conditions, but who makes it? In this article, we’ll explore the manufacturer behind this important medication, as well as the other innovative treatments they have developed over the years. From their impressive portfolio of products to their commitment to patient safety, we’ll take a closer look at the company behind Adalimumab and the role they play in the lives of those who rely on their medications.

Adalimumab is a prescription drug made by AbbVie. It is a type of biologic, which is a special type of drug made in living cells. Adalimumab is used to treat a variety of conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s Disease, ankylosing spondylitis, and juvenile idiopathic arthritis.

Who Makes Adalimumab?

Adalimumab is a prescription medication used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. It works by blocking the activity of tumor necrosis factor, a protein that causes inflammation in the body. Adalimumab is a type of biologic therapy, which means it is made from living organisms.

Who Makes Adalimumab

Manufacturing

Adalimumab is manufactured by AbbVie, a biopharmaceutical company that was founded in 2013 as a spin-off of Abbott Laboratories. AbbVie has its headquarters in North Chicago, Illinois, and is a global leader in the research, development, and manufacturing of biopharmaceuticals, medical devices, diagnostics, and nutrition products.

The manufacturing process for adalimumab is an intricate, multi-step process. It begins with the extraction of proteins from a genetically modified organism, followed by purification, concentration, and formulation steps. The finished product is then tested and packaged, and shipped to pharmacies and hospitals.

Distribution

Adalimumab is distributed in the United States and around the world by AbbVie and its partner companies. In the United States, adalimumab is available by prescription through pharmacies and by mail order.

Safety

Adalimumab is an FDA-approved medication, and is generally considered safe when taken as directed. As with any medication, there are potential side effects, and patients should discuss the risks and benefits of adalimumab with their doctor before beginning treatment.

Summary

Adalimumab is a biologic therapy used to treat a variety of autoimmune diseases. It is manufactured by AbbVie, a biopharmaceutical company based in North Chicago, Illinois. Adalimumab is distributed in the United States and around the world by AbbVie and its partner companies, and is available by prescription through pharmacies and by mail order. Adalimumab is an FDA-approved medication, and is generally considered safe when taken as directed.

Few Frequently Asked Questions

Who Makes Adalimumab?

Answer: Adalimumab is a biologic drug that is manufactured by AbbVie Inc., a research-based biopharmaceutical company. AbbVie was founded in 2013 as a spin-off of Abbott Laboratories and is headquartered in North Chicago, Illinois. AbbVie is a global company, with research and development centers around the world and a presence in more than 170 countries.

What is Adalimumab Used to Treat?

Answer: Adalimumab is a type of biologic drug that is used to treat a variety of autoimmune and inflammatory conditions. It is approved by the U.S. Food and Drug Administration (FDA) to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and pediatric Crohn’s disease. It is also approved to treat moderate to severe hidradenitis suppurativa, a chronic skin condition.

How Does Adalimumab Work?

Answer: Adalimumab works by targeting and interfering with the activity of tumor necrosis factor (TNF), a protein involved in the body’s inflammatory response. By blocking the action of TNF, adalimumab can reduce inflammation and slow the progression of autoimmune and inflammatory conditions.

What Are the Side Effects of Adalimumab?

Answer: Common side effects of adalimumab include injection site reactions, upper respiratory infections, headaches, nausea, and diarrhea. Rare but serious side effects can include infection, lupus-like syndrome, and an increased risk of certain cancers. It is important to discuss the potential risks and benefits of adalimumab with a healthcare provider before starting treatment.

What is the Cost of Adalimumab?

Answer: The cost of adalimumab will vary depending on the pharmacy and insurance coverage. Without insurance, the cost can range from $3,000 to $4,000 for a month’s supply of the drug. However, many insurance plans cover adalimumab and may reduce or eliminate the cost for the patient.

How is Adalimumab Administered?

Answer: Adalimumab is administered by subcutaneous injection, meaning that it is injected into the fatty layer of tissue just below the skin. It is typically administered once every two weeks and the injection can be done at home or in a healthcare setting. Injection sites should be rotated to reduce the risk of skin reactions.

Adalimumab is an important drug that can be life-changing for many people. It is a biologic drug manufactured by AbbVie and is used to treat a variety of conditions, including rheumatoid arthritis, Crohn’s disease, and psoriasis. By understanding the manufacturing processes and safety standards involved in producing Adalimumab, we can be confident that the drug is of the highest quality. AbbVie is committed to providing safe and effective medicines for all patients, and Adalimumab is proof of its dedication to patient care.

Leave a Reply

Your email address will not be published. Required fields are marked *